Neurodegenerative Pharmacovigilance: Deployment and Upgrade

Data Characteristics in This Category

Neurodegenerative diseases, such as Alzheimer's and Parkinson's, present distinct pharmacovigilance data characteristics. Data sources include clinical trial reports, real-world evidence (RWE), patient spontaneous reports, electronic health records (EHRs), and scientific literature. Disease progression is slow and symptoms are diverse, often leading to delayed adverse event identification. Data update frequency is relatively low, typically aggregated quarterly or semi-annually. Document structures are complex, often containing extensive unstructured text like physician notes and patient descriptions, which challenges information extraction. Beyond common adverse event coding (e.g., MedDRA terms) and patient demographics, specific indicators like disease staging, cognitive function scale scores (e.g., MMSE, MoCA), and motor function scores (e.g., UPDRS) are critical. Units involve dosage (mg), frequency (times/day), duration (years), and dimensionless values for various scores.

Constraints Imposed by These Characteristics on "Deployment and Upgrade"

The highly unstructured nature of neurodegenerative disease pharmacovigilance data necessitates strengthening text processing and natural language understanding (NLU) components during deployment. This ensures effective extraction and standardization of key information. The long data update cycles mean incremental knowledge base update strategies require optimization to reduce unnecessary full rebuilds while ensuring timely integration of new data. The presence of disease-specific scoring fields demands higher standards for data cleaning and validation rules. Pre-setting parsing logic and validation ranges for these special fields is crucial before deployment. Although the data volume is not as high as some acute diseases, the complexity and semantic correlation of unstructured data challenge vector database retrieval efficiency and context window size. During upgrades, introducing new models or optimizing algorithms requires thorough regression testing against this complex unstructured data and specific fields. This ensures the accuracy of key information extraction and relational analysis remains unaffected in the new version.

Configuration Guidelines

Configuration Item	Recommended Value	Rationale
`MAX_TEXT_CHUNK_SIZE`	`800–1200 characters`	Clinical notes and adverse reaction descriptions for neurodegenerative diseases are often long and contain rich context. This range helps preserve semantic integrity.
`OVERLAP_SIZE`	`100 characters`	Ensures sufficient overlap between adjacent chunks during text slicing to capture cross-paragraph information associations.
`VECTOR_DB_DIMENSION`	`1536`	Adapts to the dimensions of mainstream embedding models (e.g., OpenAI Ada-002), ensuring accurate vector representation.
`PARSE_FILE_TIMEOUT_SECONDS`	`600 seconds`	Processing large unstructured documents like medical records and clinical trial files requires a longer parsing time.
`MAX_CONTEXT_TOKENS`	`4096`	Provides a sufficiently long context window to aid model understanding when dealing with complex symptom descriptions and integrating multi-source information.
`RECALL_TOP_K`	`Top 10 entries`	Given the rarity and associative nature of adverse reactions in neurodegenerative diseases, appropriately increasing recall improves coverage.

Three Common Pitfalls

Model appears empty: BASE_URL in docker-compose.yml or config.json is incorrectly configured, or API_KEY is missing, preventing the system from connecting to the AI service endpoint.
Unable to converse after deployment: The AI service endpoint's API_KEY is not configured in config.json, or the configured model name does not match an available model, leading to model call failures.
File upload or parsing timeout: UPLOAD_FILE_MAX_SIZE or PARSE_FILE_TIMEOUT_SECONDS is set too low, preventing processing of large clinical reports or medical files.

Verification Steps

Upload a PDF document containing neurodegenerative disease clinical notes and adverse reaction descriptions to the FastGPT interface. Verify that the knowledge base correctly parses and generates text segments.
Perform dialogue tests using queries that include specific neurodegenerative disease symptoms and treatment plans. Observe if the AI response accurately references knowledge base content and provides relevant information. Verify that key fields (e.g., cognitive scores, medication dosages) are correctly identified.
Check system logs to ensure no AI model connection failures, file parsing timeouts, or vector database write errors occur. Confirm that log levels are appropriately set.

The values provided are common starting points. Measure them against your own samples.

Question material comes from public community discussions. Configuration values are common starting points and should be measured against your own samples. Verified on 2026-09-21.